Global X HealthTech ETF (NASDAQ:HEAL) Short Interest Up 596.8% in June

Global X HealthTech ETF (NASDAQ:HEAL) was the target of a significant increase in short interest in June. As of June 15th, there was short interest totaling 37,633 shares, an increase of 596.8% from the May 31st total of 5,401 shares. Currently, 3.8% of the company’s stock are short sold. Based on an average daily volume of 8,253 shares, the short-interest ratio is presently 4.6 days.

Institutional Trading of Global X HealthTech ETF

Institutional investors and hedge funds have recently bought and sold shares of the stock. Daiwa Securities Group Inc. bought a new position in Global X HealthTech ETF in the third quarter valued at approximately $11,239,000. WT Wealth Management raised its stake in shares of Global X HealthTech ETF by 14.7% during the 1st quarter. WT Wealth Management now owns 101,116 shares of the company’s stock worth $2,409,000 after purchasing an additional 12,945 shares in the last quarter. Flow Traders U.S. LLC bought a new stake in shares of Global X HealthTech ETF during the 3rd quarter worth approximately $368,000. Raymond James Financial Inc. bought a new stake in shares of Global X HealthTech ETF during the 3rd quarter worth approximately $274,000. Finally, Citadel Advisors LLC acquired a new stake in shares of Global X HealthTech ETF in the 3rd quarter valued at approximately $216,000.

Global X HealthTech ETF Price Performance

Shares of NASDAQ:HEAL opened at $27.63 on Friday. The company’s 50-day moving average price is $25.44 and its two-hundred day moving average price is $26.74. Global X HealthTech ETF has a one year low of $23.00 and a one year high of $33.59. The stock has a market capitalization of $27.63 million, a PE ratio of 42.80 and a beta of 1.12.

About Global X HealthTech ETF

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.